H9C2 cells were bought from ATCC (Rockville, MD, USA). All cells were maintained in
Dulbecco’s Modified Eagle medium (Thermo Fisher Scientific, Waltham, MA, USA) with 10%
fetal bovine serum (Thermo Fisher Scientific) and 1% antibiotics (Beyotime, Shanghai, China) under the condition of 5% CO
2 and 37°C.
H9C2 cells were treated with 50, 100, 150 nmol/L
Ang II (BIOFOUNT, Beijing, China) for 48 hours to establish a cell model of MH.
In addition, different concentrations of
dronedarone (1, 5, 10 μM) (Selleck, Shanghai, China) were used to treat
Ang II-induced
H9C2 cells for 6 hours.
Chen C., Hu S., Hu H.J., Liu Z.X., Wu X.T., Zou T, & Su H. (2024). Dronedarone Attenuates Ang II-Induced Myocardial Hypertrophy Through Regulating SIRT1/FOXO3/PKIA Axis. Korean Circulation Journal, 54(4), 172-186.